NCT00624936
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
154 public trials
19 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
NCT00691015
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Completed
Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS
NCT00744536
- Conditions
- Angiogenesis, Bone Marrow Diseases, Chronic Disease, +12 more
- Locations
-
- Sunnybrook Health Sciences Centre, Odette Cancer Center Toronto, Ontario, Canada
NCT00376922
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT00513474
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
Completed
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +101 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT00755040
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Norwestern Memorial Hospital Chicago, Illinois, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- M. D. Anderson Cancer Center Houston, Texas, United States
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
NCT00104975
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States